Clinical trial IPSOC-mamma
Prospective, Non-interventional, non-controlled multicenter observational study to evaluate aspects of pharmaceutical care and the treatment of postmenopausal patients with hormone-receptor positive, HER2-receptor negative, advanced breast cancer treated with everolimus and exemestane
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Prospective observational study
|
Phase | Trial phase 3 |
Academic trial | Oui |
Sponsor | UZ-K.U.Leuven |
BECT Identifier | B322201525429 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02875951 |
Inclusion criteria | Hormono positif Her2 negatif |
Last update |